Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Procedure guideline for radioiodine test (version 2)].

M Dietlein1, J Dressler, W Eschner

  • 1Klinik und Poliklinik für Nuklearmedizin der Universität zu Köln, 50924 Cologne.

Nuklearmedizin. Nuclear Medicine
|June 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TSitologiia i genetika·2018
Same author

Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment - initial experience.

Scientific reports·2016
Same author

Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment.

Medicine·2015
Same author

Evidence of impaired carbohydrate assimilation in euthyroid patients with Hashimoto's thyroiditis.

European journal of clinical nutrition·2015
Same author

[In-patient nuclear medicine therapy in Germany from 2010 to 2012. Analysis of structured quality reports].

Nuklearmedizin. Nuclear medicine·2015
Same author

The thyroid axis 'setpoints' are significantly altered after long-term suppressive LT4 therapy.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2014
Same journal

On the utility of ChatGPT in conducting a literature review on deep learning for dopamine transporter SPECT with [¹²³I]ioflupane.

Nuklearmedizin. Nuclear medicine·2026
Same journal

McCune-Albright Syndrome with Extensive Fibrous Dysplasia Evaluated by 18F-FDG PET/CT and Whole-body Bone Scintigraphy: A Case Report.

Nuklearmedizin. Nuclear medicine·2026
Same journal

False-Positive Rib Lesion on Bone Scintigraphy and 68Ga-PSMA PET/CT: Fibrous Dysplasia Mimicking Metastasis.

Nuklearmedizin. Nuclear medicine·2026
Same journal

PSMA-exprimierende Nebennierenläsion beim Prostatakarzinom: Phäochromozytom statt Metastase.

Nuklearmedizin. Nuclear medicine·2026
Same journal

A translational journey in Germany: From literature to local implementation of [89Zr]Zr-DFO-trastuzumab.

Nuklearmedizin. Nuclear medicine·2026
Same journal

[68Ga]Ga-FAPI-04 PET/CT Delineates Peritoneal Carcinomatosis in Invasive Lobular Breast Cancer with Limited FDG Avidity.

Nuklearmedizin. Nuclear medicine·2026
See all related articles

This updated guideline details radioiodine uptake testing procedures, including optimal timing for single or repeated measurements and instrumentation like sodium iodide crystals or gamma-cameras. It also covers patient preparation and potential errors for accurate thyroid assessments.

Area of Science:

  • Nuclear medicine
  • Endocrinology
  • Medical imaging

Background:

  • The 1999 radioiodine test guideline has been updated to version 2.
  • This revision incorporates advancements and best practices in thyroid diagnostics.

Framework:

  • Discusses the advantages and disadvantages of single versus repeated iodine-131 uptake measurements.
  • Outlines optimal timing strategies for radioiodine uptake assessments.
  • Presents various formulas for calculating radioiodine kinetics based on one, two, or three data points.

Implementation:

  • Details instrumentation for iodine-131 uptake measurement, including sodium iodide crystal probes and gamma-cameras with Region of Interest (ROI) technique.
  • Highlights potential sources of error, such as inaccurate target volume measurement via sonography.

Related Experiment Videos

  • Specifies patient preparation protocols, including the withdrawal of antithyroid drugs 2-3 days prior to radioiodine administration.

    • Implications:

    • Ensures standardized and accurate radioiodine testing for improved thyroid disorder diagnosis.
    • Minimizes measurement errors through precise instrumentation and patient preparation guidelines.
    • Facilitates better clinical decision-making by providing updated protocols for radioiodine kinetic analysis.